Radiological, pathological and DNA remission in recurrent metastatic nasopharyngeal carcinoma

被引:5
|
作者
Chan, Stephen L. [1 ]
Hui, Edwin P. [1 ]
Leung, Sing F. [1 ]
Chan, Anthony T. C. [1 ]
Ma, Brigette B. Y. [1 ]
机构
[1] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Clin Oncol, Shatin, Hong Kong, Peoples R China
关键词
D O I
10.1186/1471-2407-6-259
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Circulating plasma Epstein Barr Virus DNA (EBV-DNA) is a sensitive and specific marker of nasopharyngeal carcinoma (NPC). The mainstay of treatment of metastatic NPC is systemic chemotherapy and resection for solitary metastasis. Despite high response rate to chemotherapy, complete remission is uncommonly seen. Case Presentation: We report a case of recurrent metastatic NPC in a 43-year-old man, who achieved complete remission three times with chemotherapy and surgery. Serial plasma EBV-DNA levels were measured during the course of disease. The patient had three episodes of recurrences of NPC manifested as distant metastasis. Both time, rise in the plasma EBV-DNA level preceded detection of recurrences by imaging. Following systemic chemotherapy, he achieved complete remission each time, of which was confirmed by 18-flourodeoxyglucose positron emission tomography and hepatectomy pathology. The plasma EBV-DNA level dropped to zero copy/ml at the time of each remission. Conclusion: This case highlights the high chemosensitivity of NPC by illustrating a rare occurrence of complete response of metastatic NPC to chemotherapy. This case also underscores the usefulness of EBV-DNA as a useful tool in monitoring NPC by its ability to detect early recurrence and excellent correlation with treatment response.
引用
收藏
页数:5
相关论文
共 50 条
  • [21] Efficacy and safety of apatinib in recurrent/metastatic nasopharyngeal carcinoma: A pilot study
    Huang, Luo
    Zhang, Xin
    Bai, Yu
    Chua, Kevin L. M.
    Xie, Yue
    Shu, Xiaolei
    Long, Bin
    Fan, Chunbo
    Lim, Darren W. T.
    Tan, Sze Huey
    Wee, Joseph T. S.
    Wang, Ying
    Wu, Yongzhong
    Chua, Melvin L. K.
    ORAL ONCOLOGY, 2021, 115
  • [22] CHEMOTHERAPY OF METASTATIC AND OR RECURRENT UNDIFFERENTIATED NASOPHARYNGEAL CARCINOMA WITH CISPLATIN, BLEOMYCIN, AND FLUOROURACIL
    BOUSSEN, H
    CVITKOVIC, E
    WENDLING, JL
    AZLI, N
    BACHOUCHI, M
    MAHJOUBI, R
    KALIFA, C
    WIBAULT, P
    SCHWAAB, G
    ARMAND, JP
    JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (09) : 1675 - 1681
  • [23] Comprehensive treatment of recurrent and metastatic nasopharyngeal carcinoma: advances and future directions
    Fan, Ming
    Liu, Dengqun
    Zhu, Guiquan
    Ren, Yazhou
    Feng, Mei
    PRECISION RADIATION ONCOLOGY, 2022, 6 (04): : 328 - 334
  • [24] Nasopharyngeal Brush Epstein Barr Viral DNA in the Detection of Locally Recurrent Nasopharyngeal Carcinoma
    Chan, Jason
    Lai, Ronald
    Yeung, Zenon
    Chan, Allen
    Lam, Jacky
    ORAL ONCOLOGY, 2021, 118
  • [25] Carboplatin and Pembrolizumab Chemoimmunotherapy Achieves Remission in Recurrent, Metastatic Sebaceous Carcinoma
    Kodali, Saranya
    Tipirneni, Eswar
    Gibson, Pamela C.
    Cook, Deborah
    Verschraegen, Claire
    Lane, Katherine A.
    OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY, 2018, 34 (05): : E149 - E151
  • [26] Complete Radiological Response of Recurrent Metastatic Adrenocortical Carcinoma to Pembrolizumab and Mitotane
    Alam, Walid
    Bouferraa, Youssef
    Haibe, Yolla
    Shamseddine, Ali
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2021, 15
  • [27] Case Report: Prolonged remission of metastatic cisplatin-refractory nasopharyngeal carcinoma with Pembrolizumab
    Wang, Wei Cen
    Preti, Beatrice
    Read, Nancy
    Gibson, Paul
    Kwan, Keith
    Winquist, Eric
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [28] Anlotinib for patients with recurrent or metastatic nasopharyngeal carcinoma: A phase II study.
    Cai, Qingqing
    Su, Ning
    Fang, Yu
    Zou, Qihua
    Xia, Yi
    Ma, Shuyun
    Cai, Jun
    Liu, PanPan
    Wang, Jinni
    Zhang, Yuchen
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E18020 - E18020
  • [29] Detection and staging of recurrent or metastatic nasopharyngeal carcinoma in the era of FDG PET/MR
    Yongfeng Piao
    Caineng Cao
    Yuanfan Xu
    Shuang Huang
    Feng Jiang
    Ting Jin
    Qifeng Jin
    Yonghong Hua
    Qiaoying Hu
    Xiaozhong Chen
    European Archives of Oto-Rhino-Laryngology, 2022, 279 : 353 - 359
  • [30] A Phase II trial of docetaxel and cisplatin in patients with recurrent or metastatic nasopharyngeal carcinoma
    McCarthy, JS
    Tannock, IF
    Degendorfer, P
    Panzarella, T
    Furlan, M
    Siu, LL
    ORAL ONCOLOGY, 2002, 38 (07) : 686 - 690